Characterization of drugs as antioxidant prophylactics
Identifieur interne : 002A06 ( Main/Exploration ); précédent : 002A05; suivant : 002A07Characterization of drugs as antioxidant prophylactics
Auteurs : Okezie I. Aruoma [Royaume-Uni]Source :
- Free Radical Biology and Medicine [ 0891-5849 ] ; 1996.
English descriptors
- Teeft :
- Acad, Academic press, Adduct, Agents actions, Alap, Anal, Anticancer, Anticancer drugs, Antiinflammatory, Antiinflammatory drugs, Antioxidant, Antioxidant action, Antioxidant activity, Antioxidant prophylactics, Antioxidant therapy, Apoptosis, Aromatic hydroxylation, Aruoma, Ascorbate, Ascorbic, Ascorbic acid, Assay, Atherosclerosis, Biochem, Biochemistry, Biol, Biological systems, Biophys, Breast cancer, Calcium antagonists, Captopril, Carcinogenesis, Cardiovascular, Catalase, Cell death, Chelate, Chelate iron, Chem, Clin, Commun, Copper complexes, Cytochrome, Density lipoprotein, Deoxyribose, Deoxyribose assay, Deoxyribose degradation, Deoxyribose molecule, Dismutase, Dizdaroglu, Edta, Elastase, Elli, Ellis horwood, Enzyme inhibitors, Enzymol, Etoposide, Fatty acids, Feb, Febs lett, Fenton, Fenton reaction, Food chem, Free radic, Free radicals, Free solution, Fridovich, Gallic acid, Glutathione, Gutteridge, Halliwell, Histamine, Hoc1, Hplc, Human body, Human disease, Human neutrophils, Hydrogen peroxide, Hydroxyl, Hydroxyl radicals, Hypochlorous, Hypochlorous acid, Inflammation, Inhibitor, Ion, Iron ions, Lett, Lipid, Lipid oxidation, Lipid peroxidation, Lipoprotein, Mccord, Metal complexes, Metal ions, Methods enzymol, Natl, Neutrophil, Nitric, Nitric oxide, Nonsteroidal, Nonsteroidal antiinflammatory drugs, Nutr, Other molecules, Oxidant, Oxidase, Oxidative, Oxidative damage, Oxidative stress, Oxide, Oxygen radicals, Parkinson, Penicillamine, Peroxidase, Peroxidation, Peroxide, Peroxyl, Peroxyl radicals, Peroxynitrite, Pharmacol, Pharmacology, Phenylbutazone, Proc, Prophylactic, Pryor, Pulse radiolysis, Radic, Radical reactions, Radiolysis, Rate constants, Reaction mixture, Reactive, Reactive oxygen species, Redox, Rheumatoid, Rheumatoid arthritis, Scavenge, Scavenger, Sulphasalazine, Superoxide, Superoxide dismutase, Synovial, Synovial fluid, Tamoxifen, Taylor francis, Therapeutic categories, Tion, Tissue damage, Tissue injury, Toxicity, Toxicol, Transition metal ions, Trolox, Tropical diseases, Uric, Uric acid, Vivo, Xanthine.
Abstract
Abstract: There is growing interest in the evaluation of drugs (prescription only medicines and over-the-counter medicines) as antioxidant prophylactics. Although free radical mechanism in human degenerative diseases is now generally recognised, the mechanisms of tissue injury in humans are very complex and it may not be possible to clearly identify the role played by free radicals in the process. This review examines the current evidence to support the notion that drugs for a particular therapeutic category might possess useful antioxidant capacity hence minimising tissue injury due to free radicals.
Url:
DOI: 10.1016/0891-5849(95)02110-8
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002066
- to stream Istex, to step Curation: 002066
- to stream Istex, to step Checkpoint: 001796
- to stream Main, to step Merge: 002A58
- to stream Main, to step Curation: 002A06
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Characterization of drugs as antioxidant prophylactics</title><author><name sortKey="Aruoma, Okezie I" sort="Aruoma, Okezie I" uniqKey="Aruoma O" first="Okezie I." last="Aruoma">Okezie I. Aruoma</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A392E09BE64E3FD83200C5A5192377A8944A611E</idno><date when="1996" year="1996">1996</date><idno type="doi">10.1016/0891-5849(95)02110-8</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-TT4WHVJD-5/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002066</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002066</idno><idno type="wicri:Area/Istex/Curation">002066</idno><idno type="wicri:Area/Istex/Checkpoint">001796</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001796</idno><idno type="wicri:doubleKey">0891-5849:1996:Aruoma O:characterization:of:drugs</idno><idno type="wicri:Area/Main/Merge">002A58</idno><idno type="wicri:Area/Main/Curation">002A06</idno><idno type="wicri:Area/Main/Exploration">002A06</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Characterization of drugs as antioxidant prophylactics</title><author><name sortKey="Aruoma, Okezie I" sort="Aruoma, Okezie I" uniqKey="Aruoma O" first="Okezie I." last="Aruoma">Okezie I. Aruoma</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Pharmacology Group, University of London King's College, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Free Radical Biology and Medicine</title><title level="j" type="abbrev">FRB</title><idno type="ISSN">0891-5849</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1996">1996</date><biblScope unit="volume">20</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="675">675</biblScope><biblScope unit="page" to="705">705</biblScope></imprint><idno type="ISSN">0891-5849</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0891-5849</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acad</term><term>Academic press</term><term>Adduct</term><term>Agents actions</term><term>Alap</term><term>Anal</term><term>Anticancer</term><term>Anticancer drugs</term><term>Antiinflammatory</term><term>Antiinflammatory drugs</term><term>Antioxidant</term><term>Antioxidant action</term><term>Antioxidant activity</term><term>Antioxidant prophylactics</term><term>Antioxidant therapy</term><term>Apoptosis</term><term>Aromatic hydroxylation</term><term>Aruoma</term><term>Ascorbate</term><term>Ascorbic</term><term>Ascorbic acid</term><term>Assay</term><term>Atherosclerosis</term><term>Biochem</term><term>Biochemistry</term><term>Biol</term><term>Biological systems</term><term>Biophys</term><term>Breast cancer</term><term>Calcium antagonists</term><term>Captopril</term><term>Carcinogenesis</term><term>Cardiovascular</term><term>Catalase</term><term>Cell death</term><term>Chelate</term><term>Chelate iron</term><term>Chem</term><term>Clin</term><term>Commun</term><term>Copper complexes</term><term>Cytochrome</term><term>Density lipoprotein</term><term>Deoxyribose</term><term>Deoxyribose assay</term><term>Deoxyribose degradation</term><term>Deoxyribose molecule</term><term>Dismutase</term><term>Dizdaroglu</term><term>Edta</term><term>Elastase</term><term>Elli</term><term>Ellis horwood</term><term>Enzyme inhibitors</term><term>Enzymol</term><term>Etoposide</term><term>Fatty acids</term><term>Feb</term><term>Febs lett</term><term>Fenton</term><term>Fenton reaction</term><term>Food chem</term><term>Free radic</term><term>Free radicals</term><term>Free solution</term><term>Fridovich</term><term>Gallic acid</term><term>Glutathione</term><term>Gutteridge</term><term>Halliwell</term><term>Histamine</term><term>Hoc1</term><term>Hplc</term><term>Human body</term><term>Human disease</term><term>Human neutrophils</term><term>Hydrogen peroxide</term><term>Hydroxyl</term><term>Hydroxyl radicals</term><term>Hypochlorous</term><term>Hypochlorous acid</term><term>Inflammation</term><term>Inhibitor</term><term>Ion</term><term>Iron ions</term><term>Lett</term><term>Lipid</term><term>Lipid oxidation</term><term>Lipid peroxidation</term><term>Lipoprotein</term><term>Mccord</term><term>Metal complexes</term><term>Metal ions</term><term>Methods enzymol</term><term>Natl</term><term>Neutrophil</term><term>Nitric</term><term>Nitric oxide</term><term>Nonsteroidal</term><term>Nonsteroidal antiinflammatory drugs</term><term>Nutr</term><term>Other molecules</term><term>Oxidant</term><term>Oxidase</term><term>Oxidative</term><term>Oxidative damage</term><term>Oxidative stress</term><term>Oxide</term><term>Oxygen radicals</term><term>Parkinson</term><term>Penicillamine</term><term>Peroxidase</term><term>Peroxidation</term><term>Peroxide</term><term>Peroxyl</term><term>Peroxyl radicals</term><term>Peroxynitrite</term><term>Pharmacol</term><term>Pharmacology</term><term>Phenylbutazone</term><term>Proc</term><term>Prophylactic</term><term>Pryor</term><term>Pulse radiolysis</term><term>Radic</term><term>Radical reactions</term><term>Radiolysis</term><term>Rate constants</term><term>Reaction mixture</term><term>Reactive</term><term>Reactive oxygen species</term><term>Redox</term><term>Rheumatoid</term><term>Rheumatoid arthritis</term><term>Scavenge</term><term>Scavenger</term><term>Sulphasalazine</term><term>Superoxide</term><term>Superoxide dismutase</term><term>Synovial</term><term>Synovial fluid</term><term>Tamoxifen</term><term>Taylor francis</term><term>Therapeutic categories</term><term>Tion</term><term>Tissue damage</term><term>Tissue injury</term><term>Toxicity</term><term>Toxicol</term><term>Transition metal ions</term><term>Trolox</term><term>Tropical diseases</term><term>Uric</term><term>Uric acid</term><term>Vivo</term><term>Xanthine</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: There is growing interest in the evaluation of drugs (prescription only medicines and over-the-counter medicines) as antioxidant prophylactics. Although free radical mechanism in human degenerative diseases is now generally recognised, the mechanisms of tissue injury in humans are very complex and it may not be possible to clearly identify the role played by free radicals in the process. This review examines the current evidence to support the notion that drugs for a particular therapeutic category might possess useful antioxidant capacity hence minimising tissue injury due to free radicals.</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Aruoma, Okezie I" sort="Aruoma, Okezie I" uniqKey="Aruoma O" first="Okezie I." last="Aruoma">Okezie I. Aruoma</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A06 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002A06 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:A392E09BE64E3FD83200C5A5192377A8944A611E
|texte= Characterization of drugs as antioxidant prophylactics
}}
| This area was generated with Dilib version V0.6.33. |  |